A RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF ALBIGLUTIDE AS COMPARED WITH LIRAGLUTIDE IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2010
This article has no abstract
Epistemonikos ID: 487669e9f1b101d83cda1e10654669f8d8d9ec88
First added on: Apr 16, 2025